Susquehanna International Group
LMNL

Susquehanna International Group’s Liminal BioSciences Inc. Common Shares LMNL Stock Holding History

Susquehanna International Group’s Portfolio LMNL Stock Details LMNL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-14,133
Closed -$53.7K – 13563
2023
Q1 		$53.7K Buy
+14,133
New +$65.3K ﹤0.01% 11675
2022
Q3 		– Sell
-1,976
Closed -$10K – 14460
2022
Q2 		$10K Buy
+1,976
New +$12.9K ﹤0.01% 12516
2022
Q1 		– Sell
-1,722
Closed -$19K – 14301
2021
Q4 		$19K Sell
1,722
-362
-17% -$5.42K ﹤0.01% 12838
2021
Q3 		$48K Sell
2,084
-2,370
-53% -$68.3K ﹤0.01% 12365
2021
Q2 		$173K Buy
+4,454
New +$194K ﹤0.01% 11741

Other funds holding LMNL

National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ECM
Estabrook Capital Management New York $685M AUM 26.64% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Susquehanna International Group's LMNL Position: Q2 2023 in Review

Susquehanna International Group sold out of Liminal BioSciences Inc. Common Shares (LMNL) in Q2 2023, closing a stake of 14,133 shares — an estimated $53.7K sold.

Susquehanna International Group first reported a position in LMNL in Q2 2021 and held it in 5 quarters. The position peaked at $173K in Q2 2021. 8 funds tracked by Wall St. Rank hold LMNL as of Q2 2023.

  • Susquehanna International Group reported no remaining Liminal BioSciences Inc. Common Shares position as of Q2 2023 after selling out during the quarter.
  • Susquehanna International Group sold 14,133 Liminal BioSciences Inc. Common Shares shares in Q2 2023, an estimated $53.7K.
  • Susquehanna International Group first reported a position in Liminal BioSciences Inc. Common Shares in Q2 2021 and held it in 5 quarters.
  • Susquehanna International Group's Liminal BioSciences Inc. Common Shares position peaked at $173K in Q2 2021.
  • 8 funds tracked by Wall St. Rank held Liminal BioSciences Inc. Common Shares as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.